Related Experiment Video
Updated: Sep 1, 2025

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
NADPH Oxidase 2 Has a Crucial Role in Cell Cycle Progression of Esophageal Squamous Cell Carcinoma
Hiroki Shimizu1, Keita Katsurahara1, Hiroyuki Inoue1
1Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Background:
NADPH oxidases (NOXs) are transmembrane proteins that generate reactive oxygen species. Recent studies have reported that NOXs are involved in tumor progression in various cancers. However, the expression and role of NOX2 in esophageal squamous cell carcinoma (ESCC) remain unclear. This study aimed to clarify the pathophysiologic role of NOX2 in patients with ESCC and cell lines.
Methods:
Two human ESCC cell lines (TE5 and KYSE170) were used for NOX2 transfection experiments, and the effects on cell proliferation, cell cycle, cell motility, and cell survival were analyzed. An mRNA microarray analysis was also performed to assess gene expression profiles. Additionally, NOX2 immunohistochemistry was performed on 130 primary ESCC tumor samples to assess the prognostic value of NOX2 in patients with ESCC.
Results:
NOX2 depletion significantly inhibited cell proliferation with the G0/G1 arrest and resulted in apoptosis in two cell lines. Microarray analysis revealed a strong relationship between NOX2 gene expression and the signaling pathway of cell cycle regulation by the B-cell translocation gene 2 (BTG2) family, including BTG2, CCNE2, E2F1, and CDK2 genes. Immunohistochemical staining revealed that high NOX2 protein expression was significantly associated with deeper tumor invasion and selected as one of the independent prognostic factors associated with the 5-year OS rate in patients with ESCC.
Conclusions:
NOX2 expression in ESCC cells affects tumorigenesis, especially cell cycle progression via the BTG2-related signaling pathway, as well as the prognosis of patients with ESCC. NOX2 may be a novel biomarker and therapeutic target for ESCC.
Insights
NADPH oxidase 2 (NOX2) expression drives esophageal squamous cell carcinoma (ESCC) tumorigenesis and progression. Targeting NOX2 may offer a new therapeutic strategy for ESCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- NADPH oxidases (NOXs) generate reactive oxygen species and are implicated in cancer progression.
- The specific role of NOX2 in esophageal squamous cell carcinoma (ESCC) is not well understood.
Purpose of the Study:
- To investigate the pathophysiologic role and prognostic significance of NOX2 in ESCC.
- To explore the molecular mechanisms underlying NOX2's function in ESCC.
Main Methods:
- Utilized human ESCC cell lines (TE5, KYSE170) for transfection experiments.
- Performed mRNA microarray analysis to examine gene expression profiles.
- Conducted immunohistochemistry on 130 ESCC tumor samples to assess NOX2 expression and patient prognosis.
Main Results:
- NOX2 depletion inhibited ESCC cell proliferation, induced G0/G1 cell cycle arrest, and promoted apoptosis.
- NOX2 gene expression correlated with the cell cycle regulation pathway involving BTG2 family genes (BTG2, CCNE2, E2F1, CDK2).
- High NOX2 protein expression in tumors was linked to deeper invasion and served as an independent prognostic factor for 5-year overall survival.
Conclusions:
- NOX2 expression influences ESCC tumorigenesis, cell cycle progression via the BTG2 pathway, and patient prognosis.
- NOX2 represents a potential novel biomarker and therapeutic target for esophageal squamous cell carcinoma.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
What is the Cell Cycle?

